Laurel Grove Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-30,182
| Closed | -$2.8M | – | 94 |
|
|
2018
Q2 | $2.8M | Buy |
30,182
+1,250
| +4% | +$116K | 1.48% | 24 |
|
|
2018
Q1 | $2.74M | Sell |
28,932
-150
| -0.5% | -$14.2K | 1.47% | 25 |
|
|
2017
Q4 | $2.81M | Sell |
29,082
-1,150
| -4% | -$111K | 1.46% | 22 |
|
|
2017
Q3 | $2.69M | Sell |
30,232
-2,000
| -6% | -$178K | 1.4% | 23 |
|
|
2017
Q2 | $2.34M | Hold |
32,232
| – | – | 1.24% | 27 |
|
|
2017
Q1 | $2.1M | Sell |
32,232
-750
| -2% | -$48.9K | 1.11% | 32 |
|
|
2016
Q4 | $2.07M | Buy |
32,982
+282
| +0.9% | +$17.7K | 1.13% | 31 |
|
|
2016
Q3 | $2.06M | Sell |
32,700
-150
| -0.5% | -$9.46K | 1.18% | 29 |
|
|
2016
Q2 | $2.03M | Sell |
32,850
-650
| -2% | -$40.2K | 1.22% | 32 |
|
|
2016
Q1 | $1.91M | Sell |
33,500
-200
| -0.6% | -$11.4K | 1.09% | 34 |
|
|
2015
Q4 | $2M | Sell |
33,700
-200
| -0.6% | -$11.8K | 1.12% | 35 |
|
|
2015
Q3 | $1.84M | Hold |
33,900
| – | – | 1.06% | 37 |
|
|
2015
Q2 | $2.28M | Sell |
33,900
-200
| -0.6% | -$13.4K | 1.21% | 32 |
|
|
2015
Q1 | $2M | Buy |
34,100
+1,175
| +4% | +$68.8K | 1.07% | 35 |
|
|
2014
Q4 | $2.16M | Sell |
32,925
-3,900
| -11% | -$255K | 1.23% | 30 |
|
|
2014
Q3 | $2.13M | Buy |
36,825
+100
| +0.3% | +$5.78K | 1.16% | 35 |
|
|
2014
Q2 | $2.07M | Buy |
36,725
+675
| +2% | +$38.1K | 1.15% | 35 |
|
|
2014
Q1 | $1.85M | Sell |
36,050
-1,200
| -3% | -$61.7K | 1.11% | 35 |
|
|
2013
Q4 | $1.97M | Buy |
37,250
+50
| +0.1% | +$2.64K | 1.16% | 32 |
|
|
2013
Q3 | $1.66M | Sell |
37,200
-2,900
| -7% | -$130K | 1.1% | 33 |
|
|
2013
Q2 | $1.66M | Buy |
+40,100
| New | +$1.66M | 1.18% | 29 |
|